R
Rodney L. Dunn
Researcher at University of Michigan
Publications - 297
Citations - 18097
Rodney L. Dunn is an academic researcher from University of Michigan. The author has contributed to research in topics: Prostate cancer & Prostatectomy. The author has an hindex of 64, co-authored 278 publications receiving 16813 citations. Previous affiliations of Rodney L. Dunn include National Institutes of Health & Union Pacific Railroad.
Papers
More filters
Journal ArticleDOI
Quality of life and satisfaction with outcome among prostate-cancer survivors.
Martin G. Sanda,Rodney L. Dunn,Jeff M. Michalski,Howard M. Sandler,Laurel L. Northouse,Larry Hembroff,Xihong Lin,Thomas K. Greenfield,Mark S. Litwin,Mark S. Litwin,Christopher S. Saigal,Arul Mahadevan,Eric A. Klein,Adam S. Kibel,Louis L. Pisters,Deborah A. Kuban,Irving D. Kaplan,Darien Wood,Jay P. Ciezki,Nikhil L. Shah,John T. Wei +20 more
TL;DR: Each prostate-cancer treatment was associated with a distinct pattern of change in quality-of-life domains related to urinary, sexual, bowel, and hormonal function, and these changes influenced satisfaction with treatment outcomes among patients and their spouses or partners.
Journal ArticleDOI
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
TL;DR: EPIC is a robust prostate cancer HRQOL instrument that complements prior instruments by measuring a broad spectrum of urinary, bowel, sexual, and hormonal symptoms, thereby providing a unique tool for comprehensive assessment ofHRQOL issues important in contemporary prostate cancer management.
Journal ArticleDOI
Comprehensive Comparison of Health-Related Quality of Life After Contemporary Therapies for Localized Prostate Cancer
John T. Wei,Rodney L. Dunn,Howard M. Sandler,P. William McLaughlin,James E. Montie,Mark S. Litwin,Linda V. Nyquist,Martin G. Sanda +7 more
TL;DR: Long-term HRQOL after prostate brachytherapy showed no benefit relative to radical prostatectomy or external-beam radiation and may be less favorable in some domains, and hormonal adjuvants can be associated with significant impairment.
Journal ArticleDOI
The relationship between modifiable health risks and health care expenditures: An analysis of the multi-employer HERO health risk and cost database
Ron Z. Goetzel,David R. Anderson,R W Whitmer,Ronald J. Ozminkowski,Rodney L. Dunn,Jeffrey Wasserman +5 more
TL;DR: It is concluded that common modifiable health risks are associated with short-term increases in the likelihood of incurring health expenditures and in the magnitude of those expenditures.
Journal ArticleDOI
Long-Term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality-of-Life Changes After Radical Prostatectomy, External Radiation, and Brachytherapy
David C. Miller,Martin G. Sanda,Rodney L. Dunn,James E. Montie,Hector Pimentel,Howard M. Sandler,William P. McLaughlin,John T. Wei +7 more
TL;DR: During a 4-year interval from earlier to longer-term phases of PC treatment survivorship, sexual, urinary, and bowel dysfunction remain significant concerns among early-stage PC treatment survivors, compared with control men.